Form 4: BioLargo Director Dennis E. Marshall Receives Stock Options as Compensation
SEC Form 4
Director Dennis E. Marshall receives stock options from BioLargo as compensation for services and board fees.
Summary
- Dennis E. Marshall, a director of BioLargo, Inc., received options to purchase common stock as compensation for services and board fees.
- On June 28, 2024, Marshall received an option to purchase 88,237 shares at an exercise price of $0.255, replacing a previously expired option.
- On June 30, 2024, Marshall received an additional option to purchase 73,529 shares at the same exercise price as payment for $18,750 in board fees.
- Following these transactions, Marshall beneficially owns 4,344,406 shares.
Sentiment
Score: 6
Explanation: Neutral sentiment as it reflects standard compensation practices. The impact depends on the company's future performance and the dilution effect on existing shareholders.
Positives
- The issuance of options aligns the director's interests with those of the shareholders.
- The options serve as compensation for services and board fees, conserving cash for the company.
Risks
- The exercise of these options could dilute existing shareholders' equity.
- The value of the options is dependent on the future performance of BioLargo's stock.
Future Outlook
NA
Industry Context
Granting stock options to directors is a common practice to align their interests with those of shareholders and to conserve cash, particularly for smaller companies.
Comparison to Industry Standards
- Stock option grants are a typical component of director compensation packages, especially in growth-oriented companies.
- The specific number of options and exercise price would need to be compared to similar companies in the same industry and stage of development to assess whether the grant is within industry norms.
- Companies like AquaVenture Holdings (WAAS) and OriginClear (OCLN) also in the water technology space, may offer comparable compensation packages to their directors.
Related Party Transactions
- The option grants to Dennis E. Marshall are related-party transactions as he is a director of the company.
Stakeholder Impact
- Shareholders may experience dilution if the options are exercised.
- The company benefits from conserving cash by compensating the director with options.
Key Dates
| Date | Description |
|---|---|
| 2017-02-14 | Date of Limited Power of Attorney for Section 16 Reporting Obligations |
| 2024-06-28 | Date of option grant for 88,237 shares. |
| 2024-06-28 | Option to purchase 88,237 shares exercisable. |
| 2034-06-28 | Option to purchase 88,237 shares expiration date. |
| 2024-06-30 | Date of option grant for 73,529 shares. |
| 2024-06-30 | Option to purchase 73,529 shares exercisable. |
| 2034-06-30 | Option to purchase 73,529 shares expiration date. |
| 2024-07-01 | Date of signature by attorney-in-fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.